$CTRE
CareTrust REIT, Inc. Stock $ctre

$ctre Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000162828022012634 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$46.48M	$45.75M
YoY Change	1.58%	3.18%
Cost Of Revenue	$447.0K	$0.00
YoY Change		-100.0%
Gross Profit	$46.03M	$45.75M
YoY Change	0.61%	4.47%
Gross Profit Margin	99.04%	100.0%
Selling, General & Admin	$6.635M	$5.840M
YoY Change	13.61%	28.63%
% of Gross Profit	14.41%	12.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$13.59M	$13.49M
YoY Change	0.8%	2.36%
% of Gross Profit	29.53%	29.48%
Operating Expenses	$20.21M	$19.31M
YoY Change	4.66%	5.81%
Operating Profit	$25.82M	$26.44M
YoY Change	-2.35%	3.51%
Interest Expense	$5.742M	$5.762M
YoY Change	-0.35%	-14.18%
% of Operating Profit	22.24%	21.79%
Other Income/Expense, Net
YoY Change
Pretax Income	-$43.26M	$20.49M
YoY Change	-311.15%	6.0%
Income Tax
% Of Pretax Income
Net Earnings	-$43.26M	$20.49M
YoY Change	-311.19%	6.01%
Net Earnings / Revenue	-93.09%	44.78%
Basic Earnings Per Share	-$0.45	$0.21
Diluted Earnings Per Share	-$0.45	$0.21
COMMON SHARES
Basic Shares Outstanding	96.41M shares	95.38M shares
Diluted Shares Outstanding	96.41M shares	95.39M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$26.59M	$30.50M
YoY Change	-12.83%	27.62%
Cash & Equivalents	$26.59M	$30.47M
Short-Term Investments
Other Short-Term Assets	$5.668M	$7.400M
YoY Change	-23.41%	-35.09%
Inventory
Prepaid Expenses
Receivables	$1.110M	$1.800M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$33.36M	$39.70M
YoY Change	-15.96%	7.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.418B	$1.593B
YoY Change	-10.96%	6.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$0.00
YoY Change
Other Assets	$142.5M	$1.800M
YoY Change	7818.5%	-35.71%
Total Long-Term Assets	$1.561B	$1.594B
YoY Change	-2.12%	6.71%
TOTAL ASSETS
Total Short-Term Assets	$33.36M	$39.70M
Total Long-Term Assets	$1.561B	$1.594B
Total Assets	$1.594B	$1.634B
YoY Change	-2.46%	6.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$23.79M	$16.90M
YoY Change	40.74%	9.03%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$50.69M	$42.80M
YoY Change	18.42%	8.08%
LONG-TERM LIABILITIES
Long-Term Debt	$698.7M	$665.8M
YoY Change	4.94%	16.83%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$698.7M	$665.8M
YoY Change	4.94%	16.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$50.69M	$42.80M
Total Long-Term Liabilities	$698.7M	$665.8M
Total Liabilities	$749.4M	$708.7M
YoY Change	5.74%	16.28%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.197B	$1.182B
YoY Change	1.25%	1.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$844.6M	$925.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.594B	$1.634B
YoY Change	-2.46%	6.72%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$43.26M	$20.49M
YoY Change	-311.19%	6.01%
Depreciation, Depletion And Amortization	$13.59M	$13.49M
YoY Change	0.8%	2.36%
Cash From Operating Activities	$34.58M	$33.95M
YoY Change	1.86%	-7.03%
INVESTING ACTIVITIES
Capital Expenditures	-$23.83M	-$139.5M
YoY Change	-82.92%	392.93%
Acquisitions
YoY Change
Other Investing Activities	-$239.0K	$6.200M
YoY Change	-103.85%	55.0%
Cash From Investing Activities	-$24.07M	-$133.3M
YoY Change	-81.94%	448.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$16.19M
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$3.816M	$110.9M
YoY Change	-103.44%	-1388.35%
NET CHANGE
Cash From Operating Activities	$34.58M	$33.95M
Cash From Investing Activities	-$24.07M	-$133.3M
Cash From Financing Activities	-$3.816M	$110.9M
Net Change In Cash	$6.691M	$11.55M
YoY Change	-42.07%	219.94%
FREE CASH FLOW
Cash From Operating Activities	$34.58M	$33.95M
Capital Expenditures	-$23.83M	-$139.5M
Free Cash Flow	$58.41M	$173.4M
YoY Change	-66.32%	167.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001590717
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-36181
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	CareTrust REIT, Inc.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3999490
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	905 Calle Amanecer
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Clemente
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92673
CY2022Q1	dei	City Area Code CityAreaCode	949
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	542-3130
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2022Q1	dei	Trading Symbol TradingSymbol	CTRE
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	97028742	shares
CY2022Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1402889000	USD
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1589971000	USD
CY2022Q1	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	15155000	USD
CY2021Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	15155000	USD
CY2022Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	141716000	USD
CY2021Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	4835000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26586000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19895000	USD
CY2022Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	1110000	USD
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2418000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	5668000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	7512000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	817000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1062000	USD
CY2022Q1	us-gaap	Assets Assets	1593941000	USD
CY2021Q4	us-gaap	Assets Assets	1640848000	USD
CY2022Q1	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	394484000	USD
CY2021Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	394262000	USD
CY2022Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	199189000	USD
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	199136000	USD
CY2022Q1	us-gaap	Line Of Credit LineOfCredit	105000000	USD
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	80000000	USD
CY2022Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	23785000	USD
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	25408000	USD
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	26900000	USD
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	26285000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	749358000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	725091000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Interest Expense InterestExpense	5762000	USD
CY2022Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	1420000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	96487066	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	96487066	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	96296673	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	96296673	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	965000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	963000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	5742000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1195586000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1196839000	USD
CY2022Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	351968000	USD
CY2021Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	282045000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	844583000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	915757000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1593941000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1640848000	USD
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46007000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	45246000	USD
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	469000	USD
CY2021Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	505000	USD
CY2022Q1	us-gaap	Revenues Revenues	46476000	USD
CY2021Q1	us-gaap	Revenues Revenues	45751000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13575000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13473000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2022Q1	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	59683000	USD
CY2021Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	696000	USD
CY2021Q1	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	0	USD
CY2022Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3844000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2022Q1	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	447000	USD
CY2021Q1	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	0	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5215000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5142000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	89926000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	25073000	USD
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	186000	USD
CY2021Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-192000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-43264000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	20486000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1585000	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96410000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95378000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96410000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95385000	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	915757000	USD
CY2022Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-2772000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1521000	USD
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.275
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	26659000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-43264000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	844583000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	914142000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16191000	USD
CY2021Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-1330000	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.265
CY2021Q1	us-gaap	Dividends Common Stock DividendsCommonStock	25633000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	20486000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	925441000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-43264000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	20486000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13594000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13486000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	520000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	487000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1521000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1585000	USD
CY2022Q1	us-gaap	Straight Line Rent StraightLineRent	6000	USD
CY2021Q1	us-gaap	Straight Line Rent StraightLineRent	12000	USD
CY2022Q1	us-gaap	Sales Type Lease Impairment Loss SalesTypeLeaseImpairmentLoss	977000	USD
CY2021Q1	us-gaap	Sales Type Lease Impairment Loss SalesTypeLeaseImpairmentLoss	0	USD
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	186000	USD
CY2021Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-192000	USD
CY2022Q1	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	59683000	USD
CY2021Q1	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	0	USD
CY2022Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3844000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-337000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	100000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	404000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-278000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2037000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2453000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34579000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	33949000	USD
CY2022Q1	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	21915000	USD
CY2021Q1	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	138151000	USD
CY2022Q1	ctre	Payments To Acquire Equipment Furniture And Fixtures And Develop Real Estate Assets PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets	1918000	USD
CY2021Q1	ctre	Payments To Acquire Equipment Furniture And Fixtures And Develop Real Estate Assets PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets	1319000	USD
CY2022Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	2086000	USD
CY2021Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	700000	USD
CY2022Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	888000	USD
CY2021Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	56000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	959000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	6814000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24072000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-133300000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	16191000	USD
CY2022Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	25000000	USD
CY2021Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	120000000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2772000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1330000	USD
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	26044000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	23960000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3816000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	110901000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6691000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11550000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19895000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18919000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26586000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30469000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1355000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1325000	USD
CY2022Q1	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	615000	USD
CY2021Q1	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	1673000	USD
CY2022Q1	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	7000	USD
CY2021Q1	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	358000	USD
CY2022Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	29	state
CY2022Q1	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	15200000	USD
CY2022Q1	us-gaap	Land Land	236986000	USD
CY2021Q4	us-gaap	Land Land	251787000	USD
CY2022Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1431631000	USD
CY2021Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1622019000	USD
CY2022Q1	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	95997000	USD
CY2021Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	104722000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2658000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1257000	USD
CY2022Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1767272000	USD
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1979785000	USD
CY2022Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	364383000	USD
CY2021Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	389814000	USD
CY2022Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1402889000	USD
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1589971000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	146848000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	195547000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	194202000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	194173000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	194278000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	191589000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	998873000	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	2115510000	USD
CY2022Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	46978000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	45171000	USD
CY2022Q1	us-gaap	Straight Line Rent StraightLineRent	6000	USD
CY2021Q1	us-gaap	Straight Line Rent StraightLineRent	12000	USD
CY2022Q1	ctre	Operating Lease Lease Income Adjustments For Collectibility OperatingLeaseLeaseIncomeAdjustmentsForCollectibility	977000	USD
CY2021Q1	ctre	Operating Lease Lease Income Adjustments For Collectibility OperatingLeaseLeaseIncomeAdjustmentsForCollectibility	0	USD
CY2022Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	USD
CY2021Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	63000	USD
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46007000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	45246000	USD
CY2022Q1	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	21921000	USD
CY2022Q1	ctre	Operating Leases Anticipated Initial Annual Lease Revenues OperatingLeasesAnticipatedInitialAnnualLeaseRevenues	2050000	USD
CY2022Q1	ctre	Number Of Properties Acquired NumberOfPropertiesAcquired	2	property
CY2022Q1	ctre	Number Of Beds Or Units In Properties Acquired NumberOfBedsOrUnitsInPropertiesAcquired	265	unit
CY2022Q1	ctre	Number Of Real Estate Properties To Be Repurposed NumberOfRealEstatePropertiesToBeRepurposed	3	facility
CY2022Q1	ctre	Contractual Cash Rent Attributable To Properties Held For Sale And Repurposed Percentage ContractualCashRentAttributableToPropertiesHeldForSaleAndRepurposedPercentage	0.10
CY2022Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	141700000	USD
CY2022Q1	ctre	Transferred Out Of Assets Held For Sale Not Part Of Disposal Group TransferredOutOfAssetsHeldForSaleNotPartOfDisposalGroup	4800000	USD
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	100000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	4594000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	4594000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0	USD
CY2022Q1	ctre	Financing Receivable Principal Amount FinancingReceivablePrincipalAmount	15922000	USD
CY2022Q1	us-gaap	Notes Receivable Net NotesReceivableNet	16084000	USD
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	18316000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0	USD
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	469000	USD
CY2021Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	505000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	705000000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	6327000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	698673000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	680000000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	6602000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	673398000	USD
CY2020Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	150000000	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2022Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	150000000	USD
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.275
CY2022Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2022-04-15
CY2022Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	26691000	USD
CY2022Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2022-03-31
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5000000	shares
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1521000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1585000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	10000000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-43264000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	20486000	USD
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	117000	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	119000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-43381000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-43381000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	20367000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	20367000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96410000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95378000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	7000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96410000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95385000	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	534000	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	446000	shares

Files In Submission

Name	View Source	Status
0001628280-22-012634-index-headers.html	Edgar Link	pending
0001628280-22-012634-index.html	Edgar Link	pending
0001628280-22-012634.txt	Edgar Link	pending
0001628280-22-012634-xbrl.zip	Edgar Link	pending
ctre-20220331.htm	Edgar Link	pending
ctre-20220331.xsd	Edgar Link	pending
ctre-20220331_cal.xml	Edgar Link	unprocessable
ctre-20220331_def.xml	Edgar Link	unprocessable
ctre-20220331_htm.xml	Edgar Link	completed
ctre-20220331_lab.xml	Edgar Link	unprocessable
ctre-20220331_pre.xml	Edgar Link	unprocessable
ctre20220331q1ex311.htm	Edgar Link	pending
ctre20220331q1ex312.htm	Edgar Link	pending
ctre20220331q1ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTRE
CareTrust REIT, Inc. Stock $ctre

2022 Q1 Form 10-Q Financial Statement

#000162828022012634 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTRE CareTrust REIT, Inc. Stock $ctre

2022 Q1 Form 10-Q Financial Statement

#000162828022012634 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTRE
CareTrust REIT, Inc. Stock $ctre